ストックスクリーナーアプリを入手
141.61
2.45%
-3.55
アフターアワーズ：
141.61
前日終値:
$145.16
開ける：
$144.5
24時間の取引高:
2.92M
Relative Volume:
1.09
時価総額：
$39.02B
収益：
$21.37B
当期純損益:
$1.41B
株価収益率:
35.91
EPS:
3.9437
ネットキャッシュフロー:
$3.07B
1週間 パフォーマンス:
-4.18%
1か月 パフォーマンス:
-1.30%
6か月 パフォーマンス:
-27.51%
1年 パフォーマンス:
-16.67%
1日の値動き範囲:
$140.63
$145.60
1週間の範囲:
$140.63
$149.00
52週間の値動き範囲:
$140.63
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Compare BDX vs ISRG, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Goldman | Neutral |
| 2026-02-10 | 再開されました | Barclays | Overweight |
| 2026-02-03 | 再開されました | Citigroup | Buy |
| 2025-09-25 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-02 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-05-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-12-12 | アップグレード | Citigroup | Sell → Neutral |
| 2022-07-11 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-06-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 再開されました | Raymond James | Mkt Perform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 再開されました | Goldman | Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-07 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-02-07 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-01-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-05-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 開始されました | Deutsche Bank | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-06-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-04-10 | アップグレード | Citigroup | Neutral → Buy |
| 2018-01-19 | 再開されました | BofA/Merrill | Buy |
| 2018-01-05 | アップグレード | Citigroup | Sell → Neutral |
| 2018-01-05 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2017-12-29 | 繰り返されました | Deutsche Bank | Buy |
すべてを表示
Becton Dickinson Co (BDX) 最新ニュース
BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177 - Moomoo
Becton Dickinson and Co Stock (US0758871091): Valuation Check As Shares Lag 2026 Highs - AD HOC NEWS
Is Becton, Dickinson and Company (BDX) A Good Stock To Buy Now? - Yahoo Finance
Deals tracker: Medtronic buys Scientia Vascular for $550M - Modern Healthcare
Becton Dickinson & Co Stock (US0758871091): Stock in focus after a quiet news day - AD HOC NEWS
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $170 - Moomoo
Becton Dickinson EVP Michael Garrison sells $166,628 in stock - Investing.com UK
Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 27, 2026. - marketscreener.com
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson & Co (BDX) Revenue BreakdownMain Composition - Moomoo
Becton, Dickinson and Company: - marketscreener.com
Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 19.89% Potential Upside - DirectorsTalk Interviews
Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait” - insidermonkey.com
Becton Dickinson earnings loom as investors eye post-divestiture growth By Investing.com - Investing.com
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Is It Smart To Buy Becton, Dickinson and Company (NYSE:BDX) Before It Goes Ex-Dividend? - Yahoo Finance
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
June 3, 2026Polen Thomas E Jr - Becton Dickinson
Becton Dickinson chairman, CEO Thomas E. Polen Jr. sells $404k in shares - Investing.com UK
Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS Insider - GlobeNewswire Inc.
Becton Dickinson & Co Insider Sold Shares Worth $404,511, According to a Recent SEC Filing - marketscreener.com
June 2, 2026Menziuso Peter3 - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton Dickinson & Co stock (US0758871091): Norges Bank stake highlights interest after recent earni - AD HOC NEWS
Becton, Dickinson And Company (BDX) Stock Analysis: Exploring A 23% Upside Potential - DirectorsTalk Interviews
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $163 - 富途牛牛
Becton Dickinson resumes U.S. shipments of ChloraPrep after additional testing - TradingView
Here’s Hinde Group’s Updates on Becton, Dickinson and Company (BDX) - Insider Monkey
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $161 - Moomoo
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Becton Dickinson EVP Michael Feld sells $11,051 in stock - Investing.com UK
Becton Dickinson EVP Michael Feld sells $11,051 in stock By Investing.com - Investing.com UK
Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating - Moomoo
Becton, Dickinson And Company (BDX): Evaluating Growth Potential With A 24% Upside - DirectorsTalk Interviews
Elyra Kidney Stone Laser Launch Tests Becton Dickinson Execution Story - simplywall.st
Becton, Dickinson & Co. Faces Valuation Shift Amid Declining Stock Returns and High Debt - Markets Mojo
BD Delivers Kidney Stone Care for Urology Teams with the Elyra Thulium Fiber Laser System - Finviz
New BD laser targets smoother, quieter kidney stone care procedures - Stock Titan
Becton Dickinson and Co stock (US0758871091): new €600 million notes and recent loss raise questio - AD HOC NEWS
Becton, Dickinson and Company (BDX) Announces €600 Million Notes Offering - GuruFocus
Becton Dickinson Euro Finance Issues €600 Million 3.855% Notes Due 2033 Guaranteed by BD - Minichart
Becton Dickinson subsidiary issues €600 million in 3.855% notes due 2033 - Investing.com Canada
Becton Dickinson Issues €600 Million 3.855% Notes Due 2033 to Refinance 2026 Debt - TradingView
A Look at Becton Dickinson & Co (BDX) After 3.2% Gain -- GF Value $194.45 vs Price $146.95 - GuruFocus
Nebulizers - GlobeNewswire Inc.
Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock? - Barchart.com
Becton Dickinson Co (BDX) 財務データ
収益
当期純利益
現金流量
EPS
2.58%
大文字化:
|
ボリューム (24 時間):